These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31641878)

  • 1.
    Nicastro N; Rodriguez PV; Malpetti M; Bevan-Jones WR; Simon Jones P; Passamonti L; Aigbirhio FI; O'Brien JT; Rowe JB
    J Neurol; 2020 Feb; 267(2):341-349. PubMed ID: 31641878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal neuroimaging relationships in progressive supranuclear palsy.
    Sintini I; Schwarz CG; Senjem ML; Reid RI; Botha H; Ali F; Ahlskog JE; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Parkinsonism Relat Disord; 2019 Sep; 66():56-61. PubMed ID: 31279635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [18F]-Flortaucipir and 7T MRI Study.
    Cheong I; Du Y; Smith G; Hua J; Li X; Pantelyat A
    Neurodegener Dis; 2023; 23(3-4):35-42. PubMed ID: 38527450
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Schonhaut DR; McMillan CT; Spina S; Dickerson BC; Siderowf A; Devous MD; Tsai R; Winer J; Russell DS; Litvan I; Roberson ED; Seeley WW; Grinberg LT; Kramer JH; Miller BL; Pressman P; Nasrallah I; Baker SL; Gomperts SN; Johnson KA; Grossman M; Jagust WJ; Boxer AL; Rabinovici GD
    Ann Neurol; 2017 Oct; 82(4):622-634. PubMed ID: 28980714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimaging evidence of gray and white matter damage and clinical correlates in progressive supranuclear palsy.
    Piattella MC; Upadhyay N; Bologna M; Sbardella E; Tona F; Formica A; Petsas N; Berardelli A; Pantano P
    J Neurol; 2015 Aug; 262(8):1850-8. PubMed ID: 25980906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy.
    Whitwell JL; Tosakulwong N; Schwarz CG; Botha H; Senjem ML; Spychalla AJ; Ahlskog JE; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Mov Disord; 2019 Jan; 34(1):105-113. PubMed ID: 30468693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced structural neuroimaging in progressive supranuclear palsy: Where do we stand?
    Stezin A; Lenka A; Jhunjhunwala K; Saini J; Pal PK
    Parkinsonism Relat Disord; 2017 Mar; 36():19-32. PubMed ID: 28057431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroinflammation predicts disease progression in progressive supranuclear palsy.
    Malpetti M; Passamonti L; Jones PS; Street D; Rittman T; Fryer TD; Hong YT; Vàsquez Rodriguez P; Bevan-Jones WR; Aigbirhio FI; O'Brien JT; Rowe JB
    J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):769-775. PubMed ID: 33731439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
    Passamonti L; Vázquez Rodríguez P; Hong YT; Allinson KS; Williamson D; Borchert RJ; Sami S; Cope TE; Bevan-Jones WR; Jones PS; Arnold R; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2017 Mar; 140(3):781-791. PubMed ID: 28122879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimaging correlates of gait abnormalities in progressive supranuclear palsy.
    Sintini I; Kaufman K; Botha H; Martin PR; Loushin SR; Senjem ML; Reid RI; Schwarz CG; Jack CR; Lowe VJ; Josephs KA; Whitwell JL; Ali F
    Neuroimage Clin; 2021; 32():102850. PubMed ID: 34655905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome.
    Upadhyay N; Suppa A; Piattella MC; Bologna M; Di Stasio F; Formica A; Tona F; Colosimo C; Berardelli A; Pantano P
    J Neurol; 2016 Oct; 263(10):2022-31. PubMed ID: 27411806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcortical
    Cho H; Choi JY; Hwang MS; Lee SH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2017 Jan; 32(1):134-140. PubMed ID: 27813160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.
    Brendel M; Barthel H; van Eimeren T; Marek K; Beyer L; Song M; Palleis C; Gehmeyr M; Fietzek U; Respondek G; Sauerbeck J; Nitschmann A; Zach C; Hammes J; Barbe MT; Onur O; Jessen F; Saur D; Schroeter ML; Rumpf JJ; Rullmann M; Schildan A; Patt M; Neumaier B; Barret O; Madonia J; Russell DS; Stephens A; Roeber S; Herms J; Bötzel K; Classen J; Bartenstein P; Villemagne V; Levin J; Höglinger GU; Drzezga A; Seibyl J; Sabri O
    JAMA Neurol; 2020 Nov; 77(11):1408-1419. PubMed ID: 33165511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
    Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA
    Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic potential of automated tractography in progressive supranuclear palsy variants.
    Potrusil T; Krismer F; Beliveau V; Seppi K; Müller C; Troger F; Göbel G; Steiger R; Gizewski ER; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2020 Mar; 72():65-71. PubMed ID: 32113070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in progressive supranuclear palsy-Richardson's syndrome is related to white matter damage.
    Caso F; Agosta F; Volonté MA; Ferraro PM; Tiraboschi P; Copetti M; Valsasina P; Falautano M; Comi G; Falini A; Filippi M
    Parkinsonism Relat Disord; 2016 Oct; 31():65-71. PubMed ID: 27453032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased basal ganglia binding of
    Smith R; Schain M; Nilsson C; Strandberg O; Olsson T; Hägerström D; Jögi J; Borroni E; Schöll M; Honer M; Hansson O
    Mov Disord; 2017 Jan; 32(1):108-114. PubMed ID: 27709757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI signatures of the frontotemporal lobar degeneration continuum.
    Agosta F; Galantucci S; Magnani G; Marcone A; Martinelli D; Antonietta Volontè M; Riva N; Iannaccone S; Ferraro PM; Caso F; Chiò A; Comi G; Falini A; Filippi M
    Hum Brain Mapp; 2015 Jul; 36(7):2602-14. PubMed ID: 25821176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Whitwell JL; Lowe VJ; Tosakulwong N; Weigand SD; Senjem ML; Schwarz CG; Spychalla AJ; Petersen RC; Jack CR; Josephs KA
    Mov Disord; 2017 Jan; 32(1):124-133. PubMed ID: 27787958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
    Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.